BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34339076)

  • 1. Polydatin gold nanoparticles potentiate antitumor effect of doxorubicin in Ehrlich ascites carcinoma-bearing mice.
    Samra YA; Abdelghany AM; Zaghloul RA
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22869. PubMed ID: 34339076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats.
    Tong Y; Wang K; Sheng S; Cui J
    Biosci Biotechnol Biochem; 2020 Jun; 84(6):1201-1210. PubMed ID: 31992173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer Photochemotherapy.
    Emami F; Banstola A; Vatanara A; Lee S; Kim JO; Jeong JH; Yook S
    Mol Pharm; 2019 Mar; 16(3):1184-1199. PubMed ID: 30698975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
    El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
    Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms.
    El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
    Eur J Nutr; 2018 Apr; 57(3):981-989. PubMed ID: 28229277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the Antitumor Effect of Doxorubicin with Photosensitive Metal-Organic Framework Nanoparticles against Breast Cancer.
    Jiang Q; Zhang M; Sun Q; Yin D; Xuan Z; Yang Y
    Mol Pharm; 2021 Aug; 18(8):3026-3036. PubMed ID: 34213912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of gold nanoparticle tagged snake venom protein toxin NKCT1 on Ehrlich ascites carcinoma (EAC) and EAC induced solid tumor bearing male albino mice.
    Bhowmik T; Saha PP; DasGupta AK; Gomes A
    Curr Drug Deliv; 2014; 11(5):652-64. PubMed ID: 24827982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of silver nanoparticles synthesized by gamma radiation on the cytotoxicity of doxorubicin in human cancer cell lines and experimental animals.
    Mansour HH; Eid M; El-Arnaouty MB
    Hum Exp Toxicol; 2018 Jan; 37(1):38-50. PubMed ID: 28116921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
    Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
    Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
    El-Dayem SM; Fouda FM; Ali EH; Motelp BA
    Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
    Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
    Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice.
    Wahab MH; Akoul ES; Abdel-Aziz AA
    Tumori; 2000; 86(2):157-62. PubMed ID: 10855855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
    Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
    Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.
    Monem AS; Elbialy N; Mohamed N
    Int J Pharm; 2014 Aug; 470(1-2):1-7. PubMed ID: 24792973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
    Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
    Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
    Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologically homogeneous, pH-responsive gold nanoparticles for non-invasive imaging of HeLa cancer.
    Yim MS; Hwang YS; Bang JK; Jung DW; Kim JM; Yi GR; Lee G; Ryu EK
    Nanomedicine; 2021 Jun; 34():102394. PubMed ID: 33857687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice.
    Badary OA; Al-Shabanah OA; Al-Gharably NM; Elmazar MM
    Anticancer Drugs; 1998 Oct; 9(9):809-15. PubMed ID: 9840728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin conjugated AuNP/biopolymer composites facilitate cell cycle regulation and exhibit superior tumor suppression potential in KRAS mutant colorectal cancer.
    Hung WH; Zheng JH; Lee KC; Cho EC
    J Biotechnol; 2019 Dec; 306():149-158. PubMed ID: 31568802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.